Atlas Trials

Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

Clinical trial NCT04203901 · TERMINATED

Trial details

NCT number
NCT04203901
Sponsor
CoImmune
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Renal Cell Carcinoma
Start date
2020-07-22
Primary completion
2023-09-28
Enrollment
16

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.